Clinical Trial Update: Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia [Phase 2]

View source ↗

Summary

ClinicalTrials.gov reports completing a Phase 2 trial of the COX-2 inhibitor celecoxib for preventing colorectal cancer in patients with rectal polyps or colore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED